Tyra Biosciences director granted stock options
Tyra Biosciences director Robert J. More received a grant of stock options covering 13,160 shares of common stock at an exercise price of $32.68 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Tyra Biosciences director Robert J. More received a grant of stock options covering 13,160 shares of common stock at an exercise price of $32.68 per share. The options expire on May 27, 2036 and vest in 12 equal monthly installments after May 28, 2026. Any remaining unvested portion will fully vest at the next annual stockholder meeting if it occurs before the first anniversary of the grant date, subject to his continuous service.
Insider Trade Summary
Grant/Award: 13,160 shares
Grant/Award
1 txn
Insider
MORE ROBERT J
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 13,160 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 13,160 contracts (Direct)
Footnotes (1)
- F1. The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. 1/12th of the total number of shares of common stock subject to the option vest monthly following May 28, 2026, the date of grant. In the event the next occurring annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
Key Figures
Option grant size: 13,160 shares
Exercise price: $32.68 per share
Expiration date: May 27, 2036
+2 more
5 metrics
Option grant size
13,160 shares
Stock options granted to director Robert J. More
Exercise price
$32.68 per share
Stock option exercise price for the 13,160-share grant
Expiration date
May 27, 2036
Option expiration for the director grant
Vesting schedule
1/12 monthly
Vests monthly following May 28, 2026 over 12 months
Shares after grant
13,160 derivative securities
Total stock options held after this transaction
Key Terms
Non-Employee Director Compensation Program, stock option, vest, annual meeting of the Issuer's stockholders
4 terms
Non-Employee Director Compensation Program financial
"The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program."
stock option financial
"The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vest financial
"1/12th of the total number of shares of common stock subject to the option vest monthly following May 28, 2026, the date of grant."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting of the Issuer's stockholders financial
"In the event the next occurring annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Tyra Biosciences (TYRA) report in this Form 4 filing?
Tyra Biosciences reported a stock option grant to director Robert J. More. He received options for 13,160 shares of common stock as part of the company’s non-employee director compensation program.
What is the exercise price of the Tyra Biosciences (TYRA) stock options?
The stock options have an exercise price of $32.68 per share. This means the director can purchase Tyra Biosciences common stock at $32.68 per share once the options vest and before they expire.
When do the Tyra Biosciences (TYRA) options granted to Robert J. More vest?
The options vest in 12 equal monthly installments after May 28, 2026. If the next annual stockholder meeting occurs before the first anniversary of the grant date, any remaining unvested options vest on that meeting date, subject to continuous service.
When do the newly granted Tyra Biosciences (TYRA) stock options expire?
The stock options granted to director Robert J. More expire on May 27, 2036. He must exercise any vested options before that expiration date if he wants to purchase the underlying Tyra Biosciences shares.
Is this Tyra Biosciences (TYRA) Form 4 transaction an open-market purchase or sale?
No, this Form 4 shows a grant of stock options as compensation, not an open-market trade. The director did not buy or sell shares on the market; he received options under the non-employee director compensation program.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates